miR-451: a novel biomarker and potential therapeutic target for cancer
H Bai, S Wu - OncoTargets and therapy, 2019 - Taylor & Francis
MicroRNAs (miRNAs) are endogenous, non-coding, single-stranded small RNAs involved in
a variety of cellular processes, including ontogeny, cell proliferation, differentiation, and …
a variety of cellular processes, including ontogeny, cell proliferation, differentiation, and …
The role of microRNA as clinical biomarkers for breast cancer surgery and treatment
Breast cancer is the most common cancer diagnosed in women. In recent times, survival
outcomes have improved dramatically in accordance with our enhanced understanding of …
outcomes have improved dramatically in accordance with our enhanced understanding of …
Plasma miR-21, miR-155, miR-10b, and Let-7a as the potential biomarkers for the monitoring of breast cancer patients
There is a pressing need for further studies to categorize and validate circulating microRNAs
(miRs) in breast cancer patients that can be one of the novel strategies for cancer screening …
(miRs) in breast cancer patients that can be one of the novel strategies for cancer screening …
Circulating exosomal miRNA profile during term and preterm birth pregnancies: a longitudinal study
Despite decades of research in the field of human reproduction, the mechanisms
responsible for human parturition still remain elusive. The objective of this study was to …
responsible for human parturition still remain elusive. The objective of this study was to …
Liquid biopsy to detect minimal residual disease: methodology and impact
N Honoré, R Galot, C van Marcke, N Limaye… - Cancers, 2021 - mdpi.com
Simple Summary The field of liquid biopsy is rapidly evolving. Techniques that improve
accuracy are constantly being developed, and clinicians increasingly use liquid biopsy as a …
accuracy are constantly being developed, and clinicians increasingly use liquid biopsy as a …
[PDF][PDF] In vivo and in vitro impact of miR-31 and miR-143 on the suppression of metastasis and invasion in breast cancer
S Soheilyfar, Z Velashjerdi, YS Hajizadeh, NF Maroufi… - J buon, 2018 - researchgate.net
Summary Purpose: The microRNA (miR)-31 and miR-143 are pleiotropic anti-metastatic
miRs, with an expression that decreases significantly in metastatic breast cancer cells. The …
miRs, with an expression that decreases significantly in metastatic breast cancer cells. The …
Cell-free miRNAs as non-invasive biomarkers in breast cancer: Significance in early diagnosis and metastasis prediction
D Kashyap, H Kaur - Life sciences, 2020 - Elsevier
Breast cancer is one of the genetic diseases causing a high mortality among women around
the world. Despite the availability of advanced diagnostic tools and treatment strategies, the …
the world. Despite the availability of advanced diagnostic tools and treatment strategies, the …
Circulating miRNAs as diagnostic and prognostic biomarkers in common solid tumors: focus on lung, breast, prostate cancers, and osteosarcoma
M Bottani, G Banfi, G Lombardi - Journal of clinical medicine, 2019 - mdpi.com
An early cancer diagnosis is essential to treat and manage patients, but it is difficult to
achieve this goal due to the still too low specificity and sensitivity of classical methods …
achieve this goal due to the still too low specificity and sensitivity of classical methods …
MiR-195 and its target SEMA6D regulate chemoresponse in breast cancer
Simple Summary The resistance of cancer cells to cytotoxic chemotherapy limits cure rates
in breast cancer, and a better understanding of resistance mechanisms will aid design of …
in breast cancer, and a better understanding of resistance mechanisms will aid design of …
miRNAs as therapeutic predictors and prognostic biomarkers of neoadjuvant chemotherapy in breast cancer: A systematic review and meta-analysis
Z Zhang, H Zhang, J Yu, L Xu, X Pang, Q Xiang… - Breast cancer research …, 2022 - Springer
Purpose Accumulating evidence has shown that microRNAs (miRNAs) are promising
biomarkers of neoadjuvant chemotherapy (NAC) response in breast cancer (BC). However …
biomarkers of neoadjuvant chemotherapy (NAC) response in breast cancer (BC). However …